Benefit of clopidogrel pretreatment before PCI regardless of GP IIb/IIIa inhibitor use

被引：0
|
作者：
Sabatine, M.
Hamdalla, H.
Mehta, S.
Topol, E.
Steinhubl, S.
Cannon, C.
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Univ Kentucky, Lexington, KY USA
[3] McMaster Univ, Hamilton, ON, Canada
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：862 / 862
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use
    Sabatine, Marc S.
    Hamdalla, Hussam N.
    Mehta, Shamir R.
    Fox, Keith A. A.
    Topol, Eric J.
    Steinhubl, Steven R.
    Cannon, Christopher P.
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (05) : 910 - 917
  • [2] Do gp IIb/IIIa inhibitors add benefit during PCI in patients pre-treated with clopidogrel?. a meta-analysis
    Loma-Osorio, P.
    Bosch, X.
    Guasch, E.
    Marrugat, J.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 193 - 193
  • [3] IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor?
    Swierkosz, TA
    Valettas, N
    Herrmann, HC
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2001, 52 (04) : 433 - 434
  • [4] Bolus versus bolus plus infusion of GP IIb/IIIa inhibitor in contemporary PCI practice
    Kini, AS
    Budwani, N
    Lee, P
    Kim, MC
    Das, S
    Venkatesh, T
    Prattipati, M
    Duffy, MB
    Sharma, SK
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 63A - 63A
  • [5] Optimum duration of clopidogrel pretreatment before PCI
    Pippa Murdie
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (6): : 297 - 297
  • [6] PCI-CLARITY: is clopidogrel pretreatment before PCI beneficial?
    Hannah Camm
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (12): : 610 - 610
  • [7] Mortality benefit with concomitant clopidogrel therapy and GP IIb/IIIa antagonists at the time of ad hoc percutaneous intervention
    Gumina, RJ
    Yang, EH
    Sandhu, GS
    Prasad, A
    Bresnahan, JF
    Lennon, RJ
    Rihal, CS
    Holmes, DR
    Singh, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 45B - 45B
  • [8] In the Era of Stabilize and Seal, is There a Role for GP IIb/IIIa Agents in PCI?
    Gilchrist, Ian C.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (06) : 903 - 904
  • [9] Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention
    Gumina, Richard J.
    Yang, Eric H.
    Sandhu, Gurpreet S.
    Prasad, Abhiram
    Bresnahan, John F.
    Lennon, Ryan J.
    Rihal, Charanjit S.
    Holmes, David R., Jr.
    Singh, Mandeep
    [J]. MAYO CLINIC PROCEEDINGS, 2008, 83 (09) : 995 - 1001
  • [10] Fewer vascular complications with transradial versus transfemoral GP IIb/IIIa inhibitor-assisted PCI.
    Demtrak, S
    Resnic, FS
    Simon, DI
    Eisenhauer, AC
    Rogers, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (8A): : 53I - 53I
12345